Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
April 27, 2016Experimental DermatologyOpen Access

A non‐viral gene therapy for treatment of recessive dystrophic epidermolysis bullosa

View Full Paper
Ask AI
Bookmark
Share

Authors

LCLara CutlarUniversity College DublinDZDezhong ZhouXi'an Jiaotong UniversityXHXuejun HuAir Force Engineering University

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Cutlar et al. (2016) studied this question.

synapsesocial.com/papers/6a5bb35efe4964b367569348https://doi.org/10.1111/exd.13054
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Treatment of phenylketonuria using minicircle-based naked-DNA gene transfer to murine liver2014 · 81 citations
  2. 2Human plasma as a dermal scaffold for the generation of a completely autologous bioengineered skin2004 · 212 citations
  3. 3Mechanisms of Fibroblast Cell Therapy for Dystrophic Epidermolysis Bullosa: High Stability of Collagen VII Favors Long-term Skin Integrity2009 · 122 citations
  4. 4Tailoring highly branched poly(β-amino ester)s: a synthetic platform for epidermal gene therapy2015 · 68 citations
  5. 5Keratinocyte cell lines derived from severe generalized recessive E pidermolysis B ullosa patients carrying a highly recurrent COL 7A1 homozygous mutation: models to assess cell and gene therapies in vitro and in vivo2013 · 24 citations